Invesaro

Stocks Comparison

Cadre vs STERIS: revenue, profit, margins and growth compared

Cadre brought in $610.3M of revenue in fiscal 2025, STERIS $5.9B in fiscal 2026. Revenue changed by +7.5% at Cadre and +8.7% at STERIS on the year before, so STERIS grew faster. Cadre kept 7.2% of its revenue as net profit, STERIS 13.2%. Free cash flow was $56.8M at Cadre and $972.4M at STERIS.

Side by side, latest fiscal year

CDRESTE
Fiscal year endedFY2025 (December 31, 2025)FY2026 (March 31, 2026)
Revenue$610.3M$5.9B
Revenue growth+7.5%+8.7%
Net income$44.1M$782.3M
Net margin7.2%13.2%
Free cash flow$56.8M$972.4M
Free cash flow margin9.3%16.4%
Earnings per share (diluted)$1.02$7.93
Cash$122.9M$439.6M
Debt$307.3M$1.8B
Price to earnings25.926.4
Market value$1.1B$20.4B
Dividend yield0.36%1.18%
Rank by revenue in sector#179 of 523 · Health care#55 of 523 · Health care

Over the years

Revenue
CDRE FY2021: $404.6MCDRE FY2021: $427.3MCDRE FY2022: $457.8MCDRE FY2023: $482.5MCDRE FY2024: $567.6MCDRE FY2025: $610.3MSTE FY2019: $2.8BSTE FY2020: $3BSTE FY2021: $3.1BSTE FY2022: $4.2BSTE FY2023: $4.5BSTE FY2024: $5.1BSTE FY2025: $5.5BSTE FY2026: $5.9BFY19FY20FY21FY22FY23FY24FY25FY26
CDRE $610.3MSTE $5.9B
Net income
CDRE FY2021: $38.5MCDRE FY2021: $12.7MCDRE FY2022: $5.8MCDRE FY2023: $38.6MCDRE FY2024: $36.1MCDRE FY2025: $44.1MSTE FY2019: $303.7MSTE FY2020: $407.7MSTE FY2021: $397.4MSTE FY2022: $243.9MSTE FY2023: $107MSTE FY2024: $378.2MSTE FY2025: $614.6MSTE FY2026: $782.3MFY19FY20FY21FY22FY23FY24FY25FY26
CDRE $44.1MSTE $782.3M
Net margin
CDRE FY2021: 9.5%CDRE FY2021: 3.0%CDRE FY2022: 1.3%CDRE FY2023: 8.0%CDRE FY2024: 6.4%CDRE FY2025: 7.2%STE FY2019: 10.9%STE FY2020: 13.5%STE FY2021: 12.8%STE FY2022: 5.8%STE FY2023: 2.4%STE FY2024: 7.4%STE FY2025: 11.3%STE FY2026: 13.2%FY19FY20FY21FY22FY23FY24FY25FY26
CDRE 7.2%STE 13.2%
Revenue growth
CDRE FY2021: +5.6%CDRE FY2022: +7.1%CDRE FY2023: +5.4%CDRE FY2024: +17.6%CDRE FY2025: +7.5%STE FY2020: +8.9%STE FY2021: +2.5%STE FY2022: +35.9%STE FY2023: +7.4%STE FY2024: +13.3%STE FY2025: +6.2%STE FY2026: +8.7%FY20FY21FY22FY23FY24FY25FY26
CDRE +7.5%STE +8.7%
Free cash flow
CDRE FY2021: $40.7MCDRE FY2021: $37.3MCDRE FY2022: $41.9MCDRE FY2023: $66.5MCDRE FY2024: $26.1MCDRE FY2025: $56.8MSTE FY2019: $349.8MSTE FY2020: $376MSTE FY2021: $450.4MSTE FY2022: $397.2MSTE FY2023: $395MSTE FY2024: $613MSTE FY2025: $778MSTE FY2026: $972.4MFY19FY20FY21FY22FY23FY24FY25FY26
CDRE $56.8MSTE $972.4M

Fiscal years as each company reports them; the two may end in different months.

Questions about Cadre and STERIS

Which is bigger by revenue, Cadre or STERIS?

STERIS is bigger by revenue: $5.9B in fiscal 2026, against $610.3M for Cadre in fiscal 2025.

Which keeps more of its revenue as profit, Cadre or STERIS?

Cadre had a net margin of 7.2% in fiscal 2025; STERIS had 13.2% in fiscal 2026.

Which grew revenue faster, Cadre or STERIS?

In their latest fiscal years revenue changed by +7.5% at Cadre and +8.7% at STERIS.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies